Fremanezumab for preventing migraine

2nd September 2020 by Dr Louise Hudman

Fremanezumab for preventing migraine

This is a new guideline from NICE advising that we can use fremanezumab for preventing migraine in selected populations. It was published in June 2020.

It can be used if:

  • the migraine is chronic ie 15 or more headache days each month for at least 3 months, with at least 8 of those days having features of migraine AND
  • at least three preventative drugs have failed AND
  • it is provided according to the commercial agreements with the company.

It should be stopped if it does not reduce migraine frequency by 30% after 12 weeks of treatment.

Read for free

Sign up to access everything.

Three-month free trial

Login

Already a member? Login to view this content.

Login

"LocumDeck is self-explanatory and having never made/sent an invoice before it's made my life a lot easier, and made me feel reassured I hadn’t forgotten anything important.

I’ve recommended it to my colleague/friend who is also starting out as a GP locum."

Dr Christine Vickery

Dr Christine Vickery

See the full list of features within our NASGP membership plans

Membership